226 related articles for article (PubMed ID: 8314321)
1. Chromosomal deletions in anaplastic meningiomas suggest multiple regions outside chromosome 22 as important in tumor progression.
Lindblom A; Ruttledge M; Collins VP; Nordenskjöld M; Dumanski JP
Int J Cancer; 1994 Feb; 56(3):354-7. PubMed ID: 8314321
[TBL] [Abstract][Full Text] [Related]
2. Allelic losses at 1p, 9q, 10q, 14q, and 22q in the progression of aggressive meningiomas and undifferentiated meningeal sarcomas.
Lamszus K; Kluwe L; Matschke J; Meissner H; Laas R; Westphal M
Cancer Genet Cytogenet; 1999 Apr; 110(2):103-10. PubMed ID: 10214357
[TBL] [Abstract][Full Text] [Related]
3. Loss of heterozygosity on chromosome 22q and 17p correlates with aggressiveness of meningiomas.
Kim JH; Lee SH; Rhee CH; Park SY; Lee JH
J Neurooncol; 1998 Nov; 40(2):101-6. PubMed ID: 9892091
[TBL] [Abstract][Full Text] [Related]
4. Allelic loss at 1p is associated with tumor progression of meningiomas.
Bello MJ; de Campos JM; Kusak ME; Vaquero J; Sarasa JL; Pestaña A; Rey JA
Genes Chromosomes Cancer; 1994 Apr; 9(4):296-8. PubMed ID: 7519053
[TBL] [Abstract][Full Text] [Related]
5. Loss of heterozygosity for loci on chromosome 10 is associated with morphologically malignant meningioma progression.
Rempel SA; Schwechheimer K; Davis RL; Cavenee WK; Rosenblum ML
Cancer Res; 1993 May; 53(10 Suppl):2386-92. PubMed ID: 8485725
[TBL] [Abstract][Full Text] [Related]
6. 1p and 3p deletions in meningiomas without detectable aberrations of chromosome 22 identified by comparative genomic hybridization.
Carlson KM; Bruder C; Nordenskjöld M; Dumanski JP
Genes Chromosomes Cancer; 1997 Dec; 20(4):419-24. PubMed ID: 9408760
[TBL] [Abstract][Full Text] [Related]
7. Meningiomas: analysis of loss of heterozygosity on chromosome 10 in tumor progression and the delineation of four regions of chromosomal deletion in common with other cancers.
Mihaila D; Gutiérrez JA; Rosenblum ML; Newsham IF; Bögler O; Rempel SA;
Clin Cancer Res; 2003 Oct; 9(12):4435-42. PubMed ID: 14555516
[TBL] [Abstract][Full Text] [Related]
8. Frequent loss of chromosome 14 in atypical and malignant meningioma: identification of a putative 'tumor progression' locus.
Menon AG; Rutter JL; von Sattel JP; Synder H; Murdoch C; Blumenfeld A; Martuza RL; von Deimling A; Gusella JF; Houseal TW
Oncogene; 1997 Feb; 14(5):611-6. PubMed ID: 9053860
[TBL] [Abstract][Full Text] [Related]
9. Screening for mutations in the neurofibromatosis type 2 (NF2) gene in sporadic meningiomas.
De Vitis LR; Tedde A; Vitelli F; Ammannati F; Mennonna P; Bigozzi U; Montali E; Papi L
Hum Genet; 1996 May; 97(5):632-7. PubMed ID: 8655144
[TBL] [Abstract][Full Text] [Related]
10. Deletion mapping of the long arm of chromosome 22 in human meningiomas.
Akagi K; Kurahashi H; Arita N; Hayakawa T; Monden M; Mori T; Takai S; Nishisho I
Int J Cancer; 1995 Jan; 60(2):178-82. PubMed ID: 7829212
[TBL] [Abstract][Full Text] [Related]
11. The correlation of clinical and chromosomal alterations of benign meningiomas and their recurrences.
Och W; Szmuda T; Kulbacki K; Witek K; Sikorska B; Zakrzewska M; Springer J; Reszeć J; Parda A; Liberski PP
Neurol Neurochir Pol; 2016; 50(6):395-402. PubMed ID: 27480481
[TBL] [Abstract][Full Text] [Related]
12. Loss of heterozygosity analysis of benign, atypical, and anaplastic meningiomas.
Lee JY; Finkelstein S; Hamilton RL; Rekha R; King JT; Omalu B
Neurosurgery; 2004 Nov; 55(5):1163-73. PubMed ID: 15509323
[TBL] [Abstract][Full Text] [Related]
13. Comparative genomic hybridization analysis of genomic alterations in benign, atypical and anaplastic meningiomas.
Arslantas A; Artan S; Oner U; Durmaz R; Müslümanoğlu H; Atasoy MA; Başaran N; Tel E
Acta Neurol Belg; 2002 Jun; 102(2):53-62. PubMed ID: 12161900
[TBL] [Abstract][Full Text] [Related]
14. Deletions on chromosome 22 in sporadic meningioma.
Ruttledge MH; Xie YG; Han FY; Peyrard M; Collins VP; Nordenskjöld M; Dumanski JP
Genes Chromosomes Cancer; 1994 Jun; 10(2):122-30. PubMed ID: 7520265
[TBL] [Abstract][Full Text] [Related]
15. BCR expression is decreased in meningiomas showing loss of heterozygosity of 22q within a new minimal deletion region.
Wozniak K; Piaskowski S; Gresner SM; Golanska E; Bieniek E; Bigoszewska K; Sikorska B; Szybka M; Kulczycka-Wojdala D; Zakrzewska M; Zawlik I; Papierz W; Stawski R; Jaskolski DJ; Och W; Sieruta M; Liberski PP; Rieske P
Cancer Genet Cytogenet; 2008 May; 183(1):14-20. PubMed ID: 18474292
[TBL] [Abstract][Full Text] [Related]
16. Loss of heterozygosity of chromosome 14q in low- and high-grade meningiomas.
Tse JY; Ng HK; Lau KM; Lo KW; Poon WS; Huang DP
Hum Pathol; 1997 Jul; 28(7):779-85. PubMed ID: 9224744
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic and prognostic significance of genetic regional heterogeneity in meningiomas.
Pfisterer WK; Hank NC; Preul MC; Hendricks WP; Pueschel J; Coons SW; Scheck AC
Neuro Oncol; 2004 Oct; 6(4):290-9. PubMed ID: 15494096
[TBL] [Abstract][Full Text] [Related]
18. Identification of a consistent region of allelic loss on 1p32 in meningiomas: correlation with increased morbidity.
Sulman EP; Dumanski JP; White PS; Zhao H; Maris JM; Mathiesen T; Bruder C; Cnaan A; Brodeur GM
Cancer Res; 1998 Aug; 58(15):3226-30. PubMed ID: 9699646
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive DNA copy number profiling of meningioma using a chromosome 1 tiling path microarray identifies novel candidate tumor suppressor loci.
Buckley PG; Jarbo C; Menzel U; Mathiesen T; Scott C; Gregory SG; Langford CF; Dumanski JP
Cancer Res; 2005 Apr; 65(7):2653-61. PubMed ID: 15805262
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive genetic and epigenetic analysis of sporadic meningioma for macro-mutations on 22q and micro-mutations within the NF2 locus.
Hansson CM; Buckley PG; Grigelioniene G; Piotrowski A; Hellström AR; Mantripragada K; Jarbo C; Mathiesen T; Dumanski JP
BMC Genomics; 2007 Jan; 8():16. PubMed ID: 17222329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
